Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MOB kinase activator 3B is a member of the MOB (Mps one binder) family of kinase regulators, structurally and functionally similar to yeast Mob1. It activates or modulates kinases within the Hippo signaling pathway, which is crucial for controlling organ size via regulation of cell proliferation, apoptosis, and tumor suppression. Loss or reduced expression of MOB3B has been implicated in aggressive forms of prostate cancer and may serve as a biomarker for disease risk. The protein acts as a co-activator of LATS1 kinase, a core Hippo pathway effector, and is essential for normal mitotic checkpoint regulation and possibly other cell cycle-related processes[1][2][3][4].
Drugs (often experimental or broad-spectrum) that modulate cellular kinases or Hippo pathway components may alter MOB3B expression, affecting cell proliferation and apoptosis[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MOB kinase activator 3B (MOB3B).